Literature DB >> 21080792

Neuro-oncology, a decade of temozolomide and beyond.

Roger Stupp, Monika Hegi, Michael Weller.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 21080792     DOI： 10.1586/era.10.161

Source DB:  PubMed          Journal:  Expert Rev Anticancer Ther        ISSN： 1473-7140            Impact factor:   4.512


× No keyword cloud information.
  10 in total

1.  Thermoresponsive nanocomposite gel for local drug delivery to suppress the growth of glioma by inducing autophagy.

Authors:  Li Ding; Qi Wang; Ming Shen; Ying Sun; Xiangyu Zhang; Can Huang; Jianhua Chen; Rongxin Li; Yourong Duan
Journal:  Autophagy       Date:  2017-06-08       Impact factor: 16.016

2.  The effects of CD147 on the cell proliferation, apoptosis, invasion, and angiogenesis in glioma.

Authors:  Haoyuan Yin; Ying Shao; Xuan Chen
Journal:  Neurol Sci       Date:  2016-10-19       Impact factor: 3.307

3.  Epilysin is overexpressed in glioblastoma and related to clinical outcome of patients.

Authors:  Xuepeng Wang; Kaizhi Zhang; Xi Chen; Changfu Zhao; Zhigang Sun
Journal:  Med Oncol       Date:  2014-11-28       Impact factor: 3.064

Review 4.  Novel vaccines for glioblastoma: clinical update and perspective.

Authors:  Evan K Winograd; Michael J Ciesielski; Robert A Fenstermaker
Journal:  Immunotherapy       Date:  2016-11       Impact factor: 4.196

5.  Pushing the limits of glioma resection using electrophysiologic brain mapping.

Authors:  Pedro R Lowenstein; Maria G Castro
Journal:  J Clin Oncol       Date:  2012-04-23       Impact factor: 44.544

6.  Resistance to two heterologous neurotropic oncolytic viruses, Semliki Forest virus and vaccinia virus, in experimental glioma.

Authors:  Markus J V Vähä-Koskela; Fabrice Le Boeuf; Chantal Lemay; Naomi De Silva; Jean-Simon Diallo; Julie Cox; Michelle Becker; Youngmin Choi; Abhirami Ananth; Clara Sellers; Sophie Breton; Dominic Roy; Theresa Falls; Jan Brun; Akseli Hemminki; Ari Hinkkanen; John C Bell
Journal:  J Virol       Date:  2012-12-05       Impact factor: 5.103

7.  Prognostic significance of CD147 in patients with glioblastoma.

Authors:  Min Yang; Yang Yuan; Hua Zhang; Ming Yan; Shumei Wang; Fuqiang Feng; Peigang Ji; Yi Li; Baofu Li; Guodong Gao; Jipei Zhao; Liang Wang
Journal:  J Neurooncol       Date:  2013-08-08       Impact factor: 4.130

8.  Combined modality approaches in the management of adult glioblastoma.

Authors:  Haider A Shirazi; Sean Grimm; Jeffrey Raizer; Minesh P Mehta
Journal:  Front Oncol       Date:  2011-10-28       Impact factor: 6.244

9.  The synergic antitumor effects of paclitaxel and temozolomide co-loaded in mPEG-PLGA nanoparticles on glioblastoma cells.

Authors:  Yuanyuan Xu; Ming Shen; Yiming Li; Ying Sun; Yanwei Teng; Yi Wang; Yourong Duan
Journal:  Oncotarget       Date:  2016-04-12

10.  Increased replication stress and R-loop accumulation in EGFRvIII-expressing glioblastoma present new therapeutic opportunities.

Authors:  Nina Struve; Konstantin Hoffer; Anna-Sophie Weik; Britta Riepen; Leonie Krug; Meryem H Cetin; Jasmin Burmester; Leonie Ott; Jana Liebing; Fruzsina Gatzemeier; Justus Müller-Goebel; Mirja Gerbach; Lara Bußmann; Ann Christin Parplys; Kristian Unger; Wael Y Mansour; Ulrich Schüller; Thorsten Rieckmann; Cordula Petersen; Kai Rothkamm; Susan C Short; Malte Kriegs
Journal:  Neurooncol Adv       Date:  2021-12-04
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.